NCT03251378 A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers Status COMPLETED Phase PHASE1
NCT03176485 Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors Status COMPLETED Phase NA
NCT03073473 Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers Status TERMINATED Phase N/A
NCT02655952 Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients Status COMPLETED Phase PHASE1
NCT02618356 Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT02291744 A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients Status UNKNOWN Phase PHASE2
NCT02254941 Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer Status UNKNOWN Phase N/A
NCT01936961 Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors Status WITHDRAWN Phase NA
NCT01292356 Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor Response Status COMPLETED Phase PHASE2